App-Quantinova.ai

Effectiveness of Rivaroxaban among Patients Diagnosed With Pulmonary Embolism

Onur Baser - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Major Predictors of Long-term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-stent Strategy: Patient-level Analysis of the Korean Bifurcation Pooled Cohorts

Dong-Kie Kim - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Long-term Outcomes of Acute Coronary Syndrome Patients With High Serum D-dimer Level

Kohei Wakabayashi - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

XANTHIPPE: Examining the Effect of Ticagrelor on Platelet Activation, Platelet-Leukocyte Aggregates, and Acute Lung Injury in Pneumonia

Tracy Macaulay - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Home Monitoring is Associated With Fewer Gastrointestinal Bleeding Events Following Left Ventricular Assist Device Implantation

MItchell A Psotka - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Aspirin

Home Monitoring is Associated With Fewer Hospital Readmissions Following Left Ventricular Assist Device Implantation

Jana Svetlichnaya - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Aspirin

Untreated Iron Deficiency is Associated With an Increased Risk for Thrombotic Complications in Patients With Left Ventricular Assist Devices

Rahat Muslem - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Hydroxyzine

Impact of IVUS-guided PCI for Reducing Adverse Cardiovascular Events -One Year Data From Japanese Multicenter (KICS) Registry

Kenji Sakamoto - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Delayed Ticagrelor Pharmacodynamic Effect in ACS in the Absence of Morphine Therapy and Hemodynamic Compromise

Udaya Tantry - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Ticagrelor

Multiple Reoperations on the Mitral Valve. Results and Risk Factors for Immediate and Long-term Outcomes

Leonora Du Puymontbrun - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Mofezolac

Thrombolysis (Catheter Directed/ Systemic) in Pulmonary Embolism: Predictors and Etiologies of Readmissions

Shilpkumar Arora - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Community Pharmacist Led Atrial Fibrillation Screening Program Has the Potential to Improve Atrial Fibrillation Detection Rates and Reduce Stroke Risk

Sally E Manning - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation

Raphael Philippart - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Higher Amount of Heparin Use is a Potential Independent Risk Factor for Cardiac Tamponade and Pericardial Effusion in the Periprocedural Period of Catheter Ablation for Atrial Fibrillation With DOACs Treatment

Tadashi Fujino - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

The Impact of Insulin Provision vs. Insulin Sensitization Therapy on the Risk of Myocardial Infarction in Diabetic Smokers With Stable Ischemic Heart Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

Matthew J. Chung - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

BARI

Computational Fluid Dynamics Description of Blood Flow in a Bidirectional Glenn Shunt Supplemented With a Modified Blalock-Taussig Shunt: Relevance to Thrombosis and Power Loss

Nancy Ross-Ascuitto - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Urinary 11-Dehydro-Thromboxane B2: A Novel Thrombosis Risk Marker in LVAD Recipients

Kevin Bliden - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Progression From Paroxysmal to Sustained Atrial Fibrillation as an Increased Risk of Hospitalization for Heart Failure: The Fushimi Af Registry

Yoshimori An - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Diagnostic Ultrasound High Mechanical Index Impulses to Recanalize Extracranial and Intracranial Vessels in Acute Carotid Artery Thrombotic Occlusion

Thomas R. Porter - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Perflutren

Elevated Left Ventricular Diastolic Filling Pressure by Tissue Doppler Imaging and Silent Brain Infarction in Patients With Nonvalvular Atrial Fibrillation

Kenichi Sugioka - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts